RedHill Biopharma Ltd. (RDHL) to Present at the Stifel Nicolaus Annual Healthcare Conference
9/3/2013 9:47:21 AM
TEL-AVIV, Israel, Sept. 3, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary formulations and combinations of existing drugs, today announced that Dror Ben-Asher, the Company's Chief Executive Officer, will present an overview of the Company at the Annual Stifel Nicolaus Healthcare Conference on Thursday, September 12, 2013 at 2:40 p.m. EDT at the Four Seasons Hotel in Boston, MA. A copy of the presentation to be made by the Company has been uploaded to the Company's website and may be viewed at the following web address: http://ir.redhillbio.com/events.cfm.
Help employers find you! Check out all the jobs and post your resume.
comments powered by